Submission Details
| 510(k) Number | K241427 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 20, 2024 |
| Decision Date | September 06, 2024 |
| Days to Decision | 109 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K241427 is an FDA 510(k) clearance for the Access Syphilis, a Enzyme Linked Immunoabsorption Assay, Treponema Pallidum (Class II — Special Controls, product code LIP), submitted by Beckman Coulter, Inc. (Chaska, US). The FDA issued a Cleared decision on September 6, 2024, 109 days after receiving the submission on May 20, 2024. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3830.
| 510(k) Number | K241427 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 20, 2024 |
| Decision Date | September 06, 2024 |
| Days to Decision | 109 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LIP — Enzyme Linked Immunoabsorption Assay, Treponema Pallidum |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3830 |